Immunotherapy for breast cancer in Italy averages from $25,000 to $42,000 per course. Costs depend on the specific drug protocols, clinic tier, and the patient's diagnostic profile. In the US, similar treatments cost $70,000 on average. Italy offers savings of approximately 52%. This treatment typically includes specialist consultations, drug administration, and laboratory monitoring.
Bookimed Expert Insight: Choosing a research-heavy center like San Raffaele in Milan offers exceptional value. Dr. Bianchini Giampaolo at San Raffaele leads immunotherapy research with over 100 clinical trials. Treatment there typically runs about $6,500 to $13,500 per course. This clinic holds IRCCS accreditation from the Italian Ministry of Health. Patients access cutting-edge protocols at significantly lower rates than US university hospitals.
Why choose Italy for immunotherapy for breast cancer?
Access advanced Immunotherapy for breast cancer solutions in trusted clinics .
| Italy | Turkey | Austria | |
| Immunotherapy for breast cancer | from $25,000 | from $9,500 | from $35,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Immunotherapy for breast cancer upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Immunotherapy for breast cancer and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Immunotherapy for breast cancer journey.
Day 1 - Arrival
Day 2 - Pre-Operation
Day 3 - Immunotherapy
Day 4 - Post-Operation
Week 1 to Week 3 - Rehabilitation
Week 4 to Week 6 - Rehabilitation
Please note that each patient reacts differently to immunotherapy. Therefore, this guide might not perfectly correspond to your individual journey. Always consult with your medical team for personalized information.
Head of Breast Cancer Group at San Raffaele – Dr. Bianchini has led over 100 clinical trials exploring immunotherapy's role in breast cancer.